Making a Difference in Survival: Integrating New Therapies for Triple-Negative Breast Cancer
Explore current groundbreaking treatment approaches for triple-negative breast cancer (TNBC) through this engaging learning hub led by a multidisciplinary panel of expert faculty. This collection of CME activities includes two Tumor Boards and one Case Challenge allowing learners to customize their own educational experience.
Early-Stage TNBC: What are the Roles of PARPIs?
Virtual Panel Discussion
Explore the latest groundbreaking treatment approaches for early-stage triple-negative breast cancer (TNBC) in this engaging tumor board! The multidisciplinary panel of expert faculty will dive into a case involving a patient with early TNBC and discuss the latest data and potential roles of PARP inhibitors (PARPIs) in the first CME activity offered in this TNBC series.
Faculty: Sarah Blair, MD, Sarah Donahue, MPH, NP, AOCNP, Amir Momeni-Boroujeni, MD & Rita Nanda, MD
Release Date:
Expiration Date: August 03, 2023
TNBC Case Challenges. Test Your Treatment Skills!
Case StudyCan you make optimal treatment choices for challenging triple-negative breast cancer (TNBC) cases? Put your TNBC skills to the test in these interactive case challenges. As the third and final activity in the TNBC series, you will navigate through two cases. Education is built into the cases, on practical strategies to meet the treatment needs of diverse patients with TNBC.
Faculty: Rita Nanda, MD
Release Date:
Expiration Date: August 03, 2023
Where do Anti-TROP2 ADCs Factor into Advanced TNBC Care?
Virtual Panel DiscussionDive into additional groundbreaking treatment approaches for triple-negative breast cancer (TNBC) in this tumor board, the second in a series focused on TNBC. This multidisciplinary tumor board discusses a patient with advanced TNBC and how novel anti-TROP2 antibody drug conjugates (ADCs) therapy may play a role.
Faculty: Sarah Donahue, MPH, NP, AOCNP, Amir Momeni-Boroujeni, MD & Rita Nanda, MD
Release Date:
Expiration Date: August 03, 2023
